Flerie

Flerie is a life sciences investment company that finances and develops biotechnology and pharmaceutical businesses, from early development through commercial growth. Founded in 2011 and headquartered in Stockholm, Sweden, the company invests globally and holds a portfolio of life sciences companies at differing stages of product development and commercial expansion. Its ordinary shares are listed on Nasdaq Stockholm under the ticker FLERIE.

The investment focus spans pharmaceutical development, biotechnology and drug development, alongside tools and services for drug development. Portfolio companies are typically working on pharmaceutical and biotechnology projects intended to address unmet medical needs and broader global healthcare challenges.

Flerie describes itself as a long-term, active investor. Beyond capital, it contributes network, expertise and resources to portfolio companies to support project progression and value creation, and it invests alongside other investors. The ownership model combines portfolio-level investing with hands-on support of individual development and expansion programmes.

The firm operates across the pharmaceuticals, biotechnology, healthcare and life sciences verticals, and its portfolio spans both drug developers and providers of adjacent tools and services.